NIPER Raebareli signs MoU with Roche Pharma India to strengthen Research (See 'Corp Brief') Sonowal interacts with Crew; calls Seafarers 'unsung heroes of Global Trade' (See 'Corp Brief') ITDC, Ministry of Tribal Affairs inaugurate Capacity Building Program for Tribal Homestay Owners (See 'Corp Brief') Food Processing Industry Must Align with Nutrition Security Goals (See 'Corp Brief') Trade Marks - Quasi-judicial authorities exercising statutory powers under the Trade Marks Act must pass a reasoned & speaking order after considering evidences & submissions placed; failure to do so amounts to abdication of these functions: HC (See 'Legal Desk') Raksha Mantri to inaugurate Conclave on 'Advanced Manufacturing Technologies' (See 'Corp Brief') Govt strengthens Institutional Credit Framework for Agriculture and Allied Sectors (See 'Corp Brief') Centre encouraging cash crops in place of tobacco: Chouhan (See 'Corp Brief') Over 1 Lakh Startups have at least One-Woman Director: Govt (See 'Corp Brief') PMLA - Allegations of mala fide cannot be accepted without specific evidence against ED officials; search authorization & consequent actions are distinct from scheduled offences u/s 3 of PMLA: HC (See 'Legal Desk') MoSPI has initiated measures to strengthen accountability in data collection (See 'Corp Brief') Govt expands Youth Skill Development through NSS, Skill India Mission and NEP Initiatives (See 'Corp Brief') Govt boosts Renewable Energy Awareness Nationwide (See 'Corp Brief') Misc - Doctrine of lis pendens u/s 52 of TOPA is not applicable to transfer of property that occurs before institution of suit concerning that property, especially when transferor is not party to subsequent suit: HC (See 'Legal Desk') CCI organises 11th Edition of National Conference on Economics of Competition Law (See 'Corp Brief') India submits Report on Implementation of Nagoya Protocol for Biodiversity (See 'Corp Brief') MSME Champion Scheme progressing well towards achieving its objectives (See 'Corp Brief') A&C - Law provides award creditor with additional option to file for execution directly in court where assets are located, but this does not extinguish jurisdiction of Seat Court: HC (See 'Legal Desk') IICA convenes 5th Inter-Ministerial Consultation on Responsible Business Conduct and ESG (See 'Corp Brief') BCCL Organizes Interaction with NRS Linkage and CIL SWMA e-Auction Consumers (See 'Corp Brief') Madnaviya & Kumaraswamy lay foundation of indoor sports complex in Karnataka (See 'Corp Brief') A&C - Juridical seat of arbitration is determinative factor for conferring exclusive supervisory jurisdiction on court: HC (See 'Legal Desk') India's progress in reducing Tuberculosis Incidence has Outpaced Global Average: Nadda (See 'Corp Brief') Rs 100 crore sanctioned for Integrated Aqua Park Project in Anantnag (See 'Corp Brief') Reddy inaugurates Multiple Projects in WCL (See 'Corp Brief') PMLA - If mortgaged properties are to be auctioned by bank or settled with borrower which may result in concealment, it would be only of those properties which was considered to be assets disproportionate to known source: SAFEMA (See 'Legal Desk') Supreme Court Clears Path For Single Insolvency Proceedings Against Linked Group Companies (See CORP EINSICHT)

NIPER Raebareli signs MoU with Roche Pharma India to strengthen Research

Published: Mar 18, 2026

By TIOLCorplaws News Service

NEW DELHI, MAR 18, 2026: NATIONAL Institute of Pharmaceutical Education and Research Raebareli (NIPER Raebareli) signed a Memorandum of Understanding (MoU) with Roche Pharma India to foster academic collaboration and advance pharmaceutical education and research in India. The MoU was signed in the presence of Manoj Joshi, Secretary, Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers, at Shastri Bhawan, New Delhi.

This strategic partnership aims to bridge the gap between academic learning and real-world industry practices by equipping students and faculty with valuable insights into the evolving pharmaceutical and regulatory landscape. Under the MoU, Roche and NIPER Raebareli will collaborate on initiatives such as a certificate programme in regulatory affairs for students and industry professionals, guest lecture series by industry experts on emerging trends including AI-driven pharmaceutical research, drug development and healthcare innovation to strengthen practical industry understanding.

Manoj Joshi emphasized that India needs to strengthen its capabilities in regulatory sciences, biologics and AI in pharmaceuticals to achieve a sustained global competitive advantage and consolidate its global position. He said academia-industry collaborations are critical to fulfilling these aspirations.

The collaboration aligns with the Government's #ViksitBharat vision and the #BiopharmaShakti mission, supporting India's transition from volume-led pharmaceutical growth to value-driven innovation and reinforcing the country's global leadership in the biopharmaceutical sector.

The initiative marks an important step toward developing a future-ready workforce and fostering sustainable growth in India's life sciences ecosystem.

TIOL CORP SEARCH

TIOL GROUP WEBSITES